U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. 0.8% SELECTOGEN; 0.8% SURGISCREEN; 0.8% AFFIRMAGEN; 0.8% RESOLVE PANELS A, B, C; 0.8% POOLING SCREENING CELLS
  1. Vaccines, Blood & Biologics

0.8% SELECTOGEN; 0.8% SURGISCREEN; 0.8% AFFIRMAGEN; 0.8% RESOLVE PANELS A, B, C; 0.8% POOLING SCREENING CELLS

STN: 103778
Proper Name: Reagent Red Blood Cells
Tradename: 0.8% SELECTOGEN; 0.8% SURGISCREEN; 0.8% AFFIRMAGEN; 0.8% RESOLVE PANELS A, B, C; 0.8% POOLING SCREENING CELLS
Manufacturer: Ortho-Clinical Diagnostics, Inc.
Indication:

  • For in vitro diagnostic use
  • For the detection of unexpected blood group antibodies using the ID-Micro Typing System™ gel Test methods.

Product Information

Supporting Documents

Back to Top